ADC Therapeutics

$22.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.13%) Today
$0.00 (0.00%) As of 10:56 PM UTC after-hours

Why Robinhood?

You can buy or sell ADCT and other stocks, options, and ETFs commission-free!

About ADCT

ADC Therapeutics SA, also called ADC Therapeutics, is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors.

CEO
Christopher John Martin
Employees
208
Headquarters
Epalinges, Vaud
Founded
2011
Market Cap
1.84B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
292.07K
High Today
$23.65
Low Today
$21.76
Open Price
$22.83
Volume
453.22K
52 Week High
$56.59
52 Week Low
$21.51

ADCT Earnings

-$0.82
-$0.55
-$0.27
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market

You May Also Like

BLES
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure